# FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 1 of 76 • PUBLIC •

> Briefs, arguments, decisions, and more.

URL: https://www.frixlaw.com/law-library/documents/agency%3Aftc%3Aa4d0ff26a1d650bd

## Record

- **Collection:** Agency decision
- **Document type:** Agency decision

## Text

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 1 of 76 • PUBLIC •

PUBLIC

L&A

LOWEU ANO ASSOCIATES. PLLC

February 9, 2026
By Email and Hand Delivery
April J. Tabor
Secretary
Office of the Secretary
Federal Trade Commission
600 Pennsylvania Avenue NW
Washington, D.C. 20580
atabor@ftc.gov
Re: FTC File No. P264800
Dear Madam Secretary:
Pursuant to 16 C.F.R. § 2.10, enclosed please find World Professional Association for
Transgender Health c•wPATH")'s Petition to Quash the United States Federal Trade
Commission's Civil Investigative Demand, dated January 15, 2026, in the above-referenced
matter.

Respectfully Submitted,

Abbe David Lowell

cc via email service:

Office of the Secretary (electronicfilings@ftc.gov)
Katherine White
Jonathan Cohen
Gregory Ashe
Jenny Hitchcock
Hans Clausen
Annie Chiang
Federal Trade Commission

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 2 of 76 • PUBLIC•

PUBLIC

BEFORE THE UNITED STATES
FEDERAL TRADE COMMISSION
In the Matter of
The Civil Investigative Demand dated
January 15, 2026, to the World Professional
Association for Transgender Health

FTC File No. P264800

PETITION TO QUASH CIVIL INVESTIGATIVE DEMAND
Pursuant to 16 C.F.R. § 2.1 0(a), Petitioner World Professional Association for Transgender
Health ("WPATH") respectfully requests that the United States Federal Trade Commission quash
the Civil Investigative Demand dated January 15, 2026, ("CID"). See Exhibit 1. The CID should
be quashed in its entirety because the FTC lacks authority to issue investigative demands against
nonprofits like WPATH, because this investigation violates WPATH's constitutional rights, and
because the CID is overly broad, unduly burdensome, vague, and ambiguous.

BACKGROUND AND PROCEDURAL HISTORY
The World Professional Association for Transgender Health is a 501(c)(3) non-profit
membership organization that has been devoted to transgender health for decades. See Exhibit 3

13. Founded in 1979, WPATH's mission is to promote evidence-based care, education, research,
public policy and respect in transgender health. 1 Id. ~1 3-4; see also, Exhibit 4. WPATH is an
international membership organization, with regional affiliate organizations in Europe and the
United States, and for this reason, provides guidance and content for professionals operating in
locations with different cultures, governance, and laws. Exhibit 3

1

5, 7.

See also, WPATH Mission and Vision. available at https://www.wpath.org/about/mission-andvision.

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 3 of 76 • PUBLIC•

PUBLIC
WPATH's over 3,000 members work together to increase access to competent care and
address the needs and concerns of transgender people through collaboration of their expertise
across disciplines and specialties. Id. ,r 6. WPATH engages in a number of activities, including
offering access to the International Journal of Transgender Health, which is an independently
owned, peer•reviewed medical journal. Id. ~ 8. WPATH has also hosted educational events which
provided members and others working in transgender and gender diverse health the opportunity to
interact, collaborate, and learn from their colleagues who are leading authors, clinicians, and expert
researchers in this issue area. Id. 1 9. WPATH held educational and research symposia, courses,
and workshops to improve access to accurate and up•to•date information and research in the field
of transgender health. Id. WPATH provides a certification program and courses to members
through its Global Education Institute ("GEI"), but has recently discontinued certain education and
mentorship programs as a result of receiving this CID. Id. ,r 34. As WPATH is an organization
dedicated to transparency, information regarding its organizational structure, membership benefits
and requirements, courses, educational and research symposia, certifications, public statements,
and research are all available on its website. Id. 1 10.
In support of its mission, WPATH commissions, provides, and periodically updates its
Standards of Care, which articulate a professional consensus about the psychiatric, psychological,
medical, and surgical management of transgender and gender diverse people.

Id. ,r 11. In

September 2022, the International Journal ofTransgender Health published the Standards of Care,
Version 8 ("SOC8").2 Id ,i 12. WPATH has provided an in-depth overview of its methodology
for the development of the standards. Id. ,r 13. The evidence and materials relied upon in drafting

2

Coleman et al., Standards of Care for the Health of Transgender and Gender Diverse People,
Version 8, International Journal of Transgender Health (Sept. 2022), available at
hnps://www.tandfonline.com/doi/pdf/ l 0.1080/26895269.2022.2100644.
2

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 61 4846 -PAG E Page 4 of76 • PUBLIC •

PUBLIC
and finalizing SOC& can be found in its References section. Id. 411 14. It has also provided a list of
the SOCS contributors, organized by chapter, and disclosed non-member financing. Id. ~ 15.
WPATH does not advertise goods or services to consumers. Id. ,I 20. It does not provide
licenses or set requirements for clinicians, researchers, or other professionals to engage in their
respective professions. Id. 41122. Outside of the benefits set forth on its website, WPATH does not
provide discounts, products, or services to its members. Id 41123. WPATH provides resources and
guidance on healthcare for transgender and gender diverse individuals of all ages and nationalities
and a forum for discussion and learning, so that its members and professionals worldwide can use
its guidance, in their independent judgment, to provide respectful and ethical treatment for patients
worldwide. Id. 4111 ~7.
WPATH and its members have been targeted, harassed, and retaliated against by federal
and state government entities for the content of their speech and advocacy regarding healthcare for
transgender and gender diverse individuals.

Id. 41[ 30.

Over the last year, as the current

administration has taken a clear, public stance against gender-affirming care and WPATH itself,
WPATH and its members have been subjects of conspiracy theories, politicized attacks, and
harassment. Id. 1 31 .
On January 16, 2026, WPATH received a CID that contained fifteen interrogatories and
thirteen document requests, broadly calling for WPATH to produce records relating to all aspects
of its work and operations since its founding. See id. , 23; Exhibit l. It stated that the subject of
the investigation as:
Whether the Organization or any other Person ... have made, or assisted others
in making, false or unsubstantiated representations or engaged in unfair
practices in connection with the marketing and advertising of Pediatric Gender
Dysphoria Treatment ... which, according to the Organization, purports to treat
gender dysphoric or gender diverse minors, to consumers in violation of

3

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 61 4846 -PAGE Page 5 of 76 • PUBLIC •

PUBLIC
Sections 5 and 12 of the FTC Act . . . and whether FTC action to obtain
monetary relief would be in the public interest.
See Exhibit 1.

Since the issuance of the CID, WPATH has conferred with Commission Staff on January
30 and February 3, to discuss the scope, burden, and unconstitutionality of the CID, as required by
16 C.F.R. § 2.IO(a)(2). See Exhibit 2.

Despite the continuing nature of the negotiations,

Commission Staff refused to provide an extension of the deadline for this petition, nor have they
retracted this CID or even removed or narrowed requests that WPATH identified as offending its
First Amendment rights.
During these correspondences, WPATH explained its position that the FTC lacks
jurisdiction to pursue these requests against WPATH, that the First Amendment's speech and
associational protections prohibit many of the CID 's requests, and that the CID is overbroad,
irrelevant to the investigative priorities, and disproportionately burdensome on WPATH. Id.
Notwithstanding its concerns about the enforceability or constitutionality of the CID, WPATH
proposed narrowing the scope of the CID's requests and limiting the burden on WPATH by
agreeing to provide the FTC with publicly available documents, as well as certain financial
information. Commission Staff declined this proposal. Accordingly, the parties' good faith
discussions were unable to resolve the parties' disagreements, resulting in the instant Petition.
ARGUMENT

Pursuant to 16 C.F.R. § 2.1O(a), Petitioner WPATH requests that the Commission quash
the subpoena, for four reasons. First, the FTC does not have jurisdiction over WPATH-either to
investigate WPATH itself under 15 U.S.C. § 46(a) or to request third·party information under 15
U.S .C. § 57b-l. Second, the issuance of the CID violates WPATH 's First Amendment rights and
its requests seek disclosure of information that would further intrude upon WPATH's constitutional

4

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 61 4846 -PAGE Page 6 of 76 •PUBLIC•

PUBLIC
rights. Third, the CID is unduly burdensome and overly broad. Fourth, WPATH has not received
proper notice of the true scope of its expected response, as the terms and definitions used in the
CID are vague, ambiguous, and subjective.

I.

The FTC Does Not Have Jurisdiction to Issue this CID to WPATH
WPATH requests that the Commission quash the CID in its entirety, as it is predicated on

an investigation of WPATH, an entity that does not fall within its jurisdiction for investigation or
enforcement, see 15 U.S.C. §§ 44-46. To the minimal extent that the underlying investigation is
of other persons or entities, see 15 U.S.C. § 57b-l, it seeks information that is not relevant to the
investigation. The CID was therefore issued outside of the FTC's jurisdiction and should be
quashed.
The FTC "has only such jurisdiction as Congress has conferred upon it by the Federal Trade
Commission Act." Cmty. Blood Bank of Kansas City Area, Inc. v. F. TC. , 405 F.2d 1011, 1015 (8th
Cir. 1969). lt may only investigate persons, partnerships, or "corporations," meaning entities
"organized to carry on business for [its] own profit or that of [its] members." 15 U.S.C. §§ 44-46.
While it may issue CIDs to any "person," meaning "any natural person, partnership, corporation,
association, or other legal entity," that "may be in possession, custody, or control of
any documentary material or tangible things, or may have any information, relevant to unfair or
deceptive acts or practices," 15 U.S.C. 57b-1, each CID must be predicated on a lawful
investigation, and seek only information that is relevant to that investigation. To read Section 57b1 as authorizing dragnet fishing expeditions requiring production of information and
documentation, under threat of civil penalties and court enforcement, would create a backdoor
investigatory power that renders Section 46's limitation on FTC's investigatory jurisdiction
entirely superfluous.

5

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 7 of 76 • PUBLIC•

PUBLIC
A. The FTC Lacks Investigatory Jurisdiction Over WPATH.

"Non-profit organizations" like WPATH "fall outside the scope of the agency's
jurisdiction." Nat'! Fed 'n ofthe Blindv. FTC, 420 F.3d 331,334 (4th Cir. 2005). WPATH is not
a person or a partnership under Section 46. Nor is it "corporation," because it is not "organized to
carry on business for [its] own profit or that of [its] members." 15 U.S.C. § 44. While the FTC
has, on rare occasions, exercised its jurisdiction to investigate nonprofits, it is well established that
"Congress did not intend to bring within the reach of the Commission any and all nonprofit
corporations regardless of their purposes and activities." Cmty. Blood Bank, 405 F.2d at 1018.
[n the rare cases where a court or the Commission has found that a nonprofit entity is a
"corporation" within the meaning of Section 44, the entity at issue either included, as part of its
mission, that it would safeguard the profession or livelihood of its members or took actions
intentionally to create or safeguard its members' profits. See Am. Med. Ass 'n v. F.TC., 638 F.2d
443,448 (2d Cir. 1980), aff 'd, 455 U.S. 676 (1982) (finding that the American Medical Association
was a corporation because it had an objective to "safeguard the material interests of the medical
profession," "actively lobbie[d] for legislation that it believe(d] may be for the profit of its
members," and "render(ed] business advice to its members."); F.T.C. v. Nat 'I Comm 'non Egg

Nutrition, 517 F.2d 485, 487 (7th Cir. 1975) (finding that a nonprofit that was formed to protect
'"the general interests of the egg industry,' according to its articles of incorporation and bylaws"
was a "corporation").
WPATH does not operate for its own profit or for the profit of its members, see Exhibit 3

fl 17, 19, and meets all requirements of a "true" nonprofit. FTC v. AmeriDebt, Inc., 343 F. Supp.
2d 451 , 460 (D. Md. 2004) (listing "whether the entity is organized as a non-profit; the manner in
which it uses and distributes realized profit; its provision of charitable purposes as a primary or

6

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846-PAGE Page 8 of76 •PUBLIC •

PUBLIC
secondary goal; and its use of non-profit status as an instrumentality of individuals or others
seeking monetary gain."). It is a 501(c)(3) with the mission of promoting evidence-based care,
education, research, public policy and respect in transgender healthcare. Exhibit 3 ,i 3. Its directors
and committee members are all volunteers, and its revenue is used "to perpetuate or expand itself
as part of its nonprofit mission." Fed. Trade Comm 'n v. Grand Canyon Educ., Inc., 745 F. Supp.
3d 803, 825 (D. Ariz. 2024); Exhibit 3 ,i,i 3, 18, 19. Moreover, WPATH has not, and frankly could
not, operate to further the profit of its members. Exhibit 3 ,i 17. WPATH's members are not limited
to a single profession, trade, practice, or even country. Members with voting rights in the
organization include professionals in a variety of disciplines, such as medicine, social work,
education, and law, actively working or retired from their fields. Exhibit 4 at 10. WPATH's
members on its Executive Committee and Board of Directors reflect these diverse specialties and
professions. It is not an association that advocates on behalf of a profession or profit-making
enterprise, but rather for ethical, evidence-based, and accessible healthcare for transgender
individuals.

While WPATH endeavors to provide resources, education, and guidance to its

members that are useful in their professional capacities, these resources and guidance are compiled
and provided for the sole purpose of promoting its mission, rather than generating or increasing
any of its members' profit. For these reasons, WPATH is not a "corporation," and cannot be the
subject of an FTC investigation.
B. The CID is Predicated on an Unlawful Investigation Into WPATH.

"Agencies are also not afforded ' unfettered authority to cast about for potential
wrongdoing,"' so a CID is not valid or enforceable "when the investigation's subject matter is
outside the agency's jurisdiction." Consumer Fin. Prof. Bureau v. Accrediting Council/or lndep.

7

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 61 4846 -PAGE Page g of 76 •PUBLIC•

PUBLIC

Colleges & Schs., 854 FJ d 683, 689 (D.C. Cir. 2017) (quoting In re Sealed Case (Admin.
Subpoena), 42 F.3d 1412, 1418 (D.C. Cir. 1994)).
The Commission has the option to define the contours of an investigation "quite generally,"

FTC. v. Invention Submission Corp., 965 F.2d 1086, 1090 (D.C. Cir. 1992), but it did not do so
here. The "subject of investigation" here is ''whether the Organization"-defined as WPATH"or any other Person" has violated Sections 5 and 12 of the FTC Act " in connection with the
marketing and advertising of Pediatric Gender Dysphoria Treatment, which, according to
[WPATH], purports to treat gender dysphoric or gender diverse minors(.]" Exhibit 1 at 3. The
FTC is therefore investigating WPATH in two respects, as both a specific target of its investigation
and as an underlying source or cause of an alleged false or misleading dissemination, even if made
by another " Person." In either sense, the CID is being used to "gather and compile information
concerning, and to investigate" WPATH. 15 U.S.C. § 46. The requests themselves confinn this
interpretation, as they solely concern WPATH's organization, operations, statements, programs,
opinions, and positions, not those of other "Persons." As the FTC does not have jurisdiction to
investigate WPATH , the issuance of the CID pursuant to such an investigation is unlawful.
II.

The Issuance of the Subpoena Violates WPATH's First Amendment Rights, and
Any Compliance Would Do the Same.

The First Amendment protects WPATH's right to freely speak, associate, and petition. It
protects the rights of its members and donors to contribute, speak, and associate anonymously and
without fear of retaliation from the federal government. The Commission should quash the CID
because it was issued in violation of WPATH 's First Amendment rights and seeks disclosure of
information that would further infringe on WPATH's First Amendment rights, as well as those of
its members, donors, listeners, and associates.

8

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 10 of 76 •PUBLIC •

PUBLIC

A. The Issuance of the CID Violates WPATH's First Amendment Rights
The Commission should quash this CID in its entirety, as its issuance has violated
WPATH's First Amendment rights. See Media Maltersfor Am. v. Fed. Trade Comm 'n, No. 25-cv1959, 2025 WL 23 78009, at * 15 (D.D.C. Aug. 15, 2025).
The administration has made its stance on the rights of transgender and gender diverse
individuals clear, going so far as to deny their existence. 3 It has targeted WPATH in particular with
vitriol. 4

The FTC itself

has hosted events and made statements aligning itself with the

administration's viewpoint. 5 In this context, the issuance of this CID, which exceeds FTC's
jurisdiction and seeks information solely regarding WPATH's speech and membership that is
offensive to the current administration, is improper viewpoint discrimination and retaliation in
violation of the First Amendment.
"[T]he law is settled that ... the First Amendment prohibits government officials from
subjecting an individual to retaliatory actions ... for speaking out." Hartman v. Moore, 547 U.S.
250, 256 (2006). " When it comes to 'a person's beliefs and associations,' '[b)road and sweeping
state inquiries into these protected areas ... discourage citizens from exercising rights protected by
the Constitution. "' Americans for Prosperity Found. v. Bonta, 594 U.S. 595, 610 (2021) (quoting
Baird v. State Bar of Ariz., 401 U.S. l, 6 (1971) (plurality opinion)). The issuance of agency
compulsory process in response to those activities can have a severe chilling effect on such

3 See

Executive Order: Defending Women from Gender Ideology Extremism and Restoring
Biological Truth to The Federal Government, January 20, 2025, available at:
https://www.whitehouse.gov/presidential-actions/2025/01/defending-women-from-genderideology-extremism-and-restoring-biological-truth-to-the-federal-govemment.
4
See Executive Order 14187, Protecting Children from Chemical and Surgical Mutilation, January
28, 2025, available at: https://www.whitehouse.gov/presidential-actions/2025/0l/protectingchildren-from-chemical-and-surgical-mutilation.
5 See Transcripl ofJuly 9, 2025 Workshop: The Dangers of "Gender-Affirming Care "for Minors,
Federal
Trade
Commission,
available
at:
https://www.ftc.gov/newsevents/events/2025/07/dangers-gender-affinning-care-minors.

9

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 11 of 76 • PUBLIC •

PUBLIC
activities, as these investigations and demands are conducted on the background of threatened
court enforcement and penalties for noncompliance. Issuance of a "a sweeping and burdensome
CID calling for sensitive materials" can be "a retaliatory action sufficient to deter a person of
ordinary firmness ... from speaking again." Media Mauers, 2025 WL 2378009, at *15.
Here, WPATH and its members have engaged in activities protected by the First
Amendment, including association, speech, and advocacy for the rights and healthcare of
trans gender and gender diverse individuals. The issuance of the CID has forced WPATH to retain
counsel in response, to alert its members and staff of a litigation hold, and to spend time and
resources negotiating with the Commission and drafting this Petition. The CID has already had a
chilling effect on WPATH's ability to effectuate its mission, as well as its speech and association.
Exhibit 3134. WPATH has engaged in this process in good faith, despite the Commission's refusal
to consider alternative proposals or extensions of the timeline for this Petition. Now, the very
mechanism by which the Commission has forced WPATH to articulate the violations of its First
Amendment rights will alert the public to this investigation, and further subject WPATH to
harassment, and deter its members or future associates from engaging with WPATH, from fear of
disclosure of their activities, affiliations, and speech to a government that has articulated its intent
to punish them for their viewpoint. As the CID retaliates against WPATH for its speech, constitutes
viewpoint discrimination, and has had a chilling effect on WPATH's First Amendment rights, the
Commission should quash it before it causes further harm.
B. Disclosure of Non-Public Member Information, Communications, and Donor
Information

Outside of its general violations of WPATH's First Amendment rights, the CID seeks
specific information that, if disclosed, would violate the First Amendment rights of WPATH and
its members. See NAACP v. State ofAla. ex rel. Patterson, 357 U.S. 449, 462 (1958) (holding that

IO

FEDERAL TRADE COMMISSION l OFFICE OF THE SECRETARY l FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 12 of 76 •PUBLIC•

PUBLIC
First Amendment protects infonnation that would "adversely affect[] members' ability to pursue
their collective effort to foster beliefs by either inducing them to withdraw from the organization
or dissuading others from joining it."). This provides an additional reason for quashing the CID.
Compelled disclosure of the requested infonnation would chi!) WPATH's activities significantly.
Exhibit 3 1126-35. As stated above, these requests are content-based and rooted in viewpoint
discrimination.
"It is hardly a novel perception that compelled di sclosure of affiliation with groups engaged
in advocacy may constitute as effective a restraint on freedom of association as [other] forms of
governmental action." NAACP, 357 U.S. at 462-63. "[C]ompelled disclosure of an individual's
affiliation with an organization may, standing alone, constitute a serious intrusion on the first
amendment right to privacy of association and belief," because, particularly where "an
organization can demonstrate a pattern of harassment resulting from prior revelations of its
membership, anonymity of membership is often essential[.)" Jones v. Unknown Agents of Fed.
Election Comm 'n, 613 F.2d 864, 874 (D.C. Cir. 1979). Compelled disclosures that would "induce

members to withdraw ... and dissuade others from joining it because of fear of exposure" are
improper, NAACP, 357 U.S. at 463, absent compliance with "exacting scrutiny." Americans for
Prosperity, 594 U.S. at 607--08, 61 3.

Here, this information requested by the CID falls squarely within the First Amendment 's
protection of the freedom to associate, speak, and petition. See Perry v. Schwarzenegger, 591 F.3d
1147, 1160 (9th Cir. 2010). The CID seeks a copy or description of every instance of WPATH 's
speech regarding transgender healthcare and compels it to state its subjective beliefs before the
FTC. See Interrogatories 4, 5, 6, 7, 11, 12; Document Requests 2, 3, 4, 5, 7, 8, 9, I 0, 13. It
additionally seeks First Amendment-protected information of WPATH's members, associates,

11

FEDERAL TRADE COMMISSION l OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 13 of 76 •PUBLIC•

PUBLIC
donors, and participants. See Interrogatories 2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13; Document Requests
2, 3, 4, 5, 6, 8, 9, 10, 11, 13. The CID further seeks information that would infringe on WPATH's
First Amendment right to petition, see Interrogatories 7, 11, Document Request 8. WPATH
recognizes that the FTC has an important interest in protecting consumers, but where so much of
the responsive information sought by the CID is publicly available, where the FTC does not have
investigative or enforcement jurisdiction over WPATH, and Commission Staff are unable to
articulate the need for non-public information from WPATH in the context of this investigation,
the FTC's interest in such information is minimal, and cannot meet the heavy burden of exacting
scrutiny.
Disclosure of the above information has a high "probability that disclosure will lead to
reprisal or harassment." Black Panther Party v. Smith, 661 F.2d 1243, 1267-68 (D.C. Cir. 1981).
Many of WPATH's members, as well as their statements, points of view, research, and
participation, are public and on WPATH's website. But, as the Commission Staff has stated that it
does not seek publicly available information, the CID seeks confidential, non-public information
about WPATH, its members, stakeholders, and others that support its work, such as records of
donations, identifying information regarding members, internal communications between WPATH
staff, members' internal discussions, conversations, and detailed records or information on every
single statement that WPATH has made, to whom, and when, regarding gender-affirming care for
minors. WPATH effectuates its mission in part by providing a forum for the free exchange of
ideas, knowledge, and experience for its members. Disclosure of these exchanges, as well as the
identities of the members engaging in them, would have an insurmountable chilling effect on the
internal exchange of ideas among WPATH members, stakeholders and supporters. Exhibit 3 1,
26-35.

Disclosure would also discourage individuals (especially medical, healthcare, and

12

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 14 of 76 •PUBLIC•

PUBLIC
academic professionals), from participating in WPATH activities and events, such as educational
and research symposia, academic conferences, research surveys, book projects, and WPATH
meetings, out of fear of harassment and reprisal. Id. Even if the Commission kept this information
confidential, something that has not occurred in this administration, fear of retaliation, harassment,
and targeting by the Commission and the federal government has the same effect as fear of
harassment and harm by the public. Id. The attached declaration from Leo Lewis, WPATH's
executive director, provides further detail regarding how disclosure of the information sought by
the CID would chill the associational rights of WPATH's members, donors, stakeholders,
associates, and supporters. See id.
In light of the significant First Amendment interests at stake through the disclosure of the
information requested by the CID, and the comparatively minimal interests of the Commission in
such information, the CID should be quashed in its entirety.

Ill.

The CID Is Overbroad, Unduly Burdensome and Vague.
A CID's "nature, purposes, and scope of[] inquiry" must be reasonable. Okla. Press Pub.

Co. v. Walling, 327 U.S. 186, 209 ( I 946). A CID that is "unduly burdensome or unreasonably

broad" is not enforceable, particularly where "compliance threatens to unduly disrupt or seriously
hinder normal operations of business." FTC v. Texaco, Inc., 555 F.2d 862, 882 (D.C. Cir. 1977).
As explained above, compliance with the CID threatens WPATH 's very existence through
the impacts of disclosure on its members, affiliates, donors, and stakeholders. Moreover, the CID
is also unreasonably broad. It seeks information dating back to WPATH's founding in 1979
regarding any statement or reference to transgender healthcare- not just pediatric healthcare, as
the investigation claims. A substantial number of requests seek information far beyond the realm
of the current standards of healthcare for adolescents or children. For example, Document
Requests 4, 5, and 6 seek vast quantities of information regarding SOCS, regardless oftime period
13

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 15 of 76 •PUBLIC •

PUBLIC
or subject mailer. But only two of SOC8's eighteen chapters are directly related to treatment of
adolescents or children, and a substantial amount of SOC8 discusses norunedical interventions and
issues. Other requests seek unlimited infonnation about WPATH's trainings, educational and
research symposia, meetings, and internal processes that have little to no relationship to the core
subject matter of the investigation: advertisement and promotion of gender affirming medical care
for minors. Only a fraction of WPATH's work is related to gender affirming care for minors.
The CID suffers from an additional severe flaw, impacting not only WPATH's ability to
comply with the Commission's requests but its ability to understand the CID's actual scope and
breadth in the first place: the persistent use of vague and subjective terms and definitions. For
example, the definition of "Covered Statements" includes "implied" representations. Whether one
of WPATH's statements implies something is entirely subjective and has no possible, useable
definition. Similar issues arise when the CID requests that WPATH provide documents that
"question" or "disprove" its statements, as responsiveness to this inquiry are also subjective and
turn on an individual's background and training. Additional vague and subjective terminology
include, but are not limited to:
•

The definition of the term "Covered Statement" includes vague and subjective
terminology, such as "safe," "few side effects," "proven effective," and "lifesaving." Each of these terms means something different depending on the listener,
whether that listener is a consumer, a lawyer, a medical doctor, or an FTC
commissioner, and in order to comply with this request, WPATH would have to
hypothesize the FTC's understanding of these subjective terms.

•

The term "substantiated" is vague in the context of this CID. Commission staff
clarified that ''substantiated" is a term of art used in the advertising and consumer

14

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 16 of 76 •PUBLIC•

PUBLIC
protection context. But that is not the context of this CID's requests, as WPATH
does not advertise or promote services or goods to consumers. Instead, much of
WPATH's work is providing information on the amount and quality of evidence
supporting different types of gender-affinning care. For example, SOCS uses
defined, specific language relating to the degree and quality of evidence, and the
consensus and acceptance of certain infonnation. See SOC8 at 252. In this context,
the term "substantiated" lacks sufficient specificity for consistent application.
•

The term "member," in the definition of Organization, differs from the usage of
"member" throughout the CID, but the CID provides no definition of "member" for
each different context.

•

The definition of "Pediatric Gender Dysphoria Treatment" is defined as "any
medical intervention which, according co the Organization, purports to treat gender
dysphoric or gender diverse minors, including but not limited to pubertal
suppression, hormone therapy, and surgery ...." This definition makes little sense.
The term "gender diverse" describes people with gender identities and/or
expressions that are different from social and cultural expectations attributed to
their sex assigned at birth. What would be treated is not specified by this definition.
In contrast, the term "gender dysphoria" is highly-specific and means a state of
distress or discomfort that may be experienced because a person's gender identity
differs from that which is physically and/or socially attributed to their sex assigned
at birth. It is unclear based on the definition as a whole whether the CID seeks
information on all medical treatments received by gender diverse minors- from
band-aids for scraped knees to pubertal suppression, or whether it seeks information

15

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 17 of 76 •PUBLIC•

PUBLIC
specifically for treatment of gender dysphoria alone. Finally, this definition is
entirely based on WPATH's opinion and is circular.
In light of these vague, subjective, and ambiguous terms, WPATH lacks sufficient notice
of how it can comply with the CID.

RESERVATION OF RIGHTS
By submitting this Petition to Quash, WPATH does not waive any rights to make additional
arguments against the FTC's investigation of WPATH, the CID, or both, under the FTC Act, the
United States Constitution, or any other statute or rule.

CONCLUSION
For the reasons set for above, WPATH respectfully requests that the Commission quash the
CID in its entirety. In the alternative, WPATH requests that the Commission modify or narrow the
CID, despite the fact that such modifications would not cure its jurisdictional defects or the
intrusions upon WPATH's constitutional rights.

Respectfully submitted by:

s Abbe David Lowell
Abbe David Lowell
LOWELL & ASSOCIATES, PLLC
1250 H Street, NW, Suite 250
Washington, DC 20005
Telephone: (202) 964-6110
Facsimile: (202) 964-6116
alowellpublicoutreach@lowellandassociates.com
Schuyler Standley
Isabella Oishi
LOWELL & ASSOCIATES, PLLC
1250 H Street, NW, Suite 250
Washington, DC 20005
Telephone: (202) 964-6110
Facsimile: (202) 964-6116
sstandley@lowellandassociates.com
ioishi@Jlowellandassociates.com
February 9, 2026

16

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 18 of 76 •PUBLIC•

PUBLIC
CERTIFICATE OF SERVICE

I hereby certify that, on February 9, 2026, the foregoing Petition to Quash Civil
Investigative Demand was served:
By Electronic Mail and Hand Delivery:

Office of the Secretary
Federal Trade Commission
600 Pennsylvania Avenue, N. W.
Washington D.C. 20580
electronicfilings@ftc.gov
April Tabor, Secretary of the Commission
Federal Trade Commission
600 Pennsylvania Avenue, N.W.
Washington D.C. 20580
atabor@ftc.gov
By Electronic Mail:

Katherine White
Deputy Secretary
Federal Trade Commission
600 Pennsylvania Avenue, N.W.
Washington D.C. 20580
kwhite@ftc.gov
Jonathan Cohen
Federal Trade Commission
600 Pennsylvania Avenue, N.W.
Washington D.C. 20580
jcohen2@ftc.gov
Gregory Ashe
Federal Trade Commission
600 Pennsylvania Avenue, N.W.
Washington D.C. 20580
gashe@ftc.gov
Jennie Hitchcock
Federal Trade Commission
600 Pennsylvania Avenue, N. W.
Washington D.C. 20580
jhitchcock@ftc.gov

17

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 19 of 76 •PUBLIC•

PUBLIC

Hans Clausen
Federal Trade Commission
600 Pennsylvania Avenue, N.W.
Washington D.C. 20580
hclausen@ftc.gov
Annie Chiang
Federal Trade Commission
600 Pennsylvania Avenue, N.W.
Washington D.C. 20580
achiang@ftc.gov

By: Isl Abbe David Lowell
Abbe David Lowell
LOWELL & ASSOCIATES, PLLC

18

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 20 of 76 • PUBLIC •

PUBLIC

Exhibit 1

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 21 of 76 • PUBLIC•

0
V

,

United States of America
Federal Trade Commission

.

PUBLIC

Civil Investigative Demand
1a. MATTER NUMBER

1. TO

Wortd Professional Association for Transgender Health. lne.
c/o Northwest Registered Agent Service, Inc.
2501 Chatham Road, Suite N
Springfield, IL 62704

P2&4800

This demand is issued pursuant to Section 20 of the Federal Trade Commission Act, 15 U.S.C. § 57b-1, in the course
of an investigation to determine whether there is, has been, or may be a violation of any laws administered by the

Federal Trade Commission by conduct, activities or proposed action as described in Item 3.
2. ACTION REQUIRED

O You are required to appear and testify.
YOUR APPEARANCE WILL 8E BEFORE

LOCATION OF HEARING

DATE AND TIME OF HEARJNG OR DEPOSITION

r.;i YOY are reqYlred to prod\lc:e all documents described In the attagatOI')' or report
~ separately and fully In writing. Submlt your answers or r ~ to the Records Custodian named in Item 4 on or before the date specified b1!1ow.

You are reSt!ntiated representations or engageo in unfa r pradices in connection with the mariceling and advert,sing of Padlatric Gender Oy,ptioria Treatment (as
)':)II aie enthlec1 • •
TM Comrni881on'a Rule$ of Pnld!co require tha1 a,ry pellli0n 10 lmit or (lllasll 1111
wilnMt for tNt Comrl"iSSIOII, TIie completed tnMII VOUCllef and this dernanl:1 !lhoukl be
Clllmand be tiled within 20 ci.y, after teNlce, or, If 1he mum data ,s less than 20 days
p,e,ented to Comtri$Slon ~ tot payment. If ycu ate pe.,manemiy « temporarily
alter~- prior to 1l1e rewm dale The Mginsl and ..-.,i.,. cop!H d l>e petition mu,t
1,,..ng-.-lhanU. addNlee on lhia doin:ind ond ii w,:,ufd req1.1raexc:e:,,,ilwe
be ftt.cl -Mtt, !tie Secretllry al Ille Fedenll Trade Cotnrrlsslon. end one f»f1'/ ShOuld be
tr1Mll for you t o ~- yo,., must get prier app Value in data

,

Symbol

ASCII Character
20

l>
®

254
174
126

-

7. De-duplication: Do not use de-duplication or email threading software without FTC approval.
8. Password-Protected Files: Remove passwords prior to production. If password removal is not
possible, provide the original and production tilenames and the passwords, under separate cover.
Producing Data to the FfC

1.

Prior to production, scan all data and media for viruses and confinn they are virus-free.

2.

For productions smaller than 50 GB, submit data electronically using the FTC's secure file transfer
protocol. Contact FTC counsel for instructions. The FTC cannot accept files via Dropbox,
Google Drive, OneDrive, or other third-party file transfer sites.

3.

If you submit data using physical media:
a. Use only CDs, DVDs, flash drives, or hard drives. fonnat the media for use with Windows;
b. Use data encryption to protect any Sensitive Personally Identifiable Information or
Sensitive Health Information (as defined in the instructions), and provide passwords in
advance of delivery, under separate cover; and
c. Use a courier service (e.g., Federal Express, UPS) because heightened security measures
delay postal delivery.

4.

Provide a transmittal letter with each production that includes:
a. Production volume name (e.g., Volume I) and date of production;
b. Numeric DoclD range of all documents in the production, and any gaps in the DoclD range;
and
c. List of custodians and the DoclD range for each custodian.

-A2-

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 34 of 76 * PUBLIC*

Standard Metadata fields

PUBLIC

DAT Fllf FlflOS

OEflNmONS

PO,ULATE FIELD FOR:

Doell>

Unique 10 number for eadl docvment

AR Documents

FamilylO

Unique 10 for all documents In a fam ly including parent in and publications have global applicability, are translated into many
languages, and are not written to adhere to any one country's specific health care system or
regulations. For these reasons, WPATII has not issued specific recommendations for compliance
with the specific laws or regulations in any individual country.
8.

WP ATH engages in a number of activities, including offering access to the

International Journal of Transgender Health, which is an independently owned peer-reviewed
medical jowual.

2

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 47 of 76 • PUBLIC•

PUBLIC
9.

WPATH also hosts educational events which provide members and others working

in transgender health the opportunity to interact, collaborate, and learn from their colleagues who
are leading authors, clinicians, and expert researchers in transgender health. WPATH holds
educational symposia, courses, and workshops to improve access to accurate and up-to-date
information and research in the field of transgender health. Further information about these
symposia, courses, and workshops are available on our website.
10.

Transparency is important to WPATH.

Detailed information regarding our

organizational structure, membership benefits and requirements, courses, certifications, public
statements, symposia, workshops, and research are all available on our website.
11.

WPATH's mission is also served by issuing clinical guidelines.

WPATH is

internationally recognized for establishing and updating the WP ATH Standards of Care ("SOC")
for the treatment and health of transgender and gender diverse people globally. These SOC
articulate a professional consensus about the psychiatric, psychological, medical, and surgical
management oftransgender and gender diverse people.
12.

In September 2022, the International Journal ofTransgender Health published the

Standards of Care, Version 8 ("SOCS"). SOCS were written to be flexible and adaptable to meet
the diverse needs of transgender and gender diverse individuals globally. The criteria in the
standards of care are clinical guidelines written to promote informed, doctor-patient decision
making on optimal care, which may include varying interventions based on individual patient
needs.
13.

The process and methodology for developing SOC8 is set forth in detail m

Appendix A of SOCS, and also are explained on the WPATII website.

3

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 48 of 76 • PUBLIC •

PUBLIC
14.

The evidence and materials considered and relied upon in drafting and finalizing

SOC8 can be found in the References section of SOC8.
15.

The names and titles of the contributors can be found on the title pages of SOC8,

as well as on WPATH's website, including descriptions of their contributions to SOCS.
16.

As a non-profit organization, WP ATH operates on a modest budget and has limited

financial resources.
17.

WPATH does not operate or aim to increase the profit of any of its members.

18.

WPATH's board of directors and executive committee are volunteers. They come

from a variety of backgrounds and specialties, including surgeons, medical professionals,
pediatricians, mental health professionals, and public policy.
19.

WPATH generates revenue primarily through membership dues, education, and its

scientific symposium, and reinvests those funds into the organization, including its standards of
care, education, global engagement, and long-tenn organizational stability.
20.

WPATH does not advertise products or services to consumers.

21.

Outside of the benefits set forth on its website, WP ATH does not provide discounts,

products, or services to its members.
22.

WP ATH does not provide licenses or set requirements for clinicians, researchers,

or other professionals to engage in their respective fields or professions.
23.

I have reviewed the CID issued on January 15, 2026, which covers a broad range

of topics and issues that relate to many different aspects of WPATH's work. WPATH received
the CID on January 16, 2026.
24.

Responding to the CID would require WPATH to expend time and resources to

provide the documents sought in the CID. The scope of these requests, in their current state, would

4

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 49 of 76 • PUBLIC•

PUBLIC
mean that I could no longer dedicate all my time to completing the daily tasks necessary to manage
the important work of the association. The scope of this search would also unduly burden my
staff, in that it would require the assistance of other team members, who would then be unable to
function in their roles at WPATH.
25.

In my view, the work I have described that would be required to respond to the CID

as drafted would distract my team from the critically important, time-sensitive work we do
advancing and improving healthcare for transgender individuals.
26.

I also view this CID, which requests our private, confidential internal

communications, as exceedingly intrusive. It requests the production of internal communications
with our members and partners, including internal chats, emails, notes, and drafts. Our members
use all of these channels to communicate with each other and engage in open discussions.
27.

Many of our members have requested that their contributions, participation, and

affiliation with WPATH remain confidential and anonymous.
28.

Based on my experience with WP ATH staff, members, and partners, I believe that

our staff, members and partners will communicate less (and less openly) if WPATH is forced to
disclose their documents, identities, and communications to the FTC. Our staff is already more
cautious in its communications for fear that they will be produced and taken out of context in an
attempt to misuse and harm the persons we are trying to help.
29.

I am also concerned that new members will fear joining WPATH if they know their

membership information, private emails, and comments shared with us and each other could
subject them to harassment arising from this litigation or other similar litigation, even when they
specifically request anonymity.

5

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 50 of 76 • PUBLIC •

PUBLIC
30.

Over the last several years as transgender health has become the subject of charged

rhetoric, WPATH's work has been considered controversial in some comers. Our members and
staff have been increasingly harassed, intimidated, and subjected to threats of harm.
31.

Our staff and members have experienced attacks via email, phone calls and

threatening voicemails, and social media messages and posts threatening and harassing them by
name. Our members are frequent targets of similar attacks. For example, recent posts on the social
media platform X have displayed our members covered in blood, and demanding they be locked
up:

32.

Members have been illegally videotaped during educational presentations and had

their intellectual property misused and edited in a manner that has led to threats of violence.

6

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 51 of 76 • PUBLIC •

PUBLIC
33.

Members and staff have been required to implement serious security measures in

response to these threats and harassment, such as installing panic buttons and conducting security
audits.
34.

As a result of receiving the CID, WPATH decided to temporarily cease offering

certain educational programs. This includes the Global Education Institute ("GEi") activities, such
as online and in-person courses, mentorship programs, and certification examination-related
functions, as well as closing the member-to-member message board, Journal Club, and the
California Health Provider Program ("HPP"}.
35.

Open, honest dialogue is also essential to the accuracy of our work and practice

recommendations, which medical professionals across many specialties use and rely on to inform
their medical decision-making. We work with thousands of medical experts every year to
understand the latest science, and to review and edit our publications, educational materials,
curriculum, and public statements. These experts are volunteers and do this work out of a need to
help improve care for transgender and gender diverse individuals. Having personally discussed
these issues with many of them for years, I know that many would think twice before volunteering
their expertise if their confidential feedback could be shared with the world. Our ability to receive
candid feedback depends on the confidence that peer reviews and communications within WP ATH
will not be publicly disclosed. Based on my experience, I believe enforcement of this subpoena
win greatly hinder the quality and accuracy of our work product, which in tum will worsen the
care that our members provide to their patients across all health domains.
I declare under penalty of perjury that the foregoing is true and correct.
Executed in Silver Spring, Maryland on February 9, 2026.

7

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 52 of 76 • PUBLIC•

PUBLIC

~
Leo Lewis

EXECUTIVE DIRECTOR, WPATH

8

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 53 of 76 • PUBLIC •

PUBLIC

Exhibit 4

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 54 of 76 • PUBLIC•

PUBLIC

I

THE WORLD PROFESSIONAL ASSOCIATION
FOR TRANSGENDER HEALTH, INC.
A NONPROFIT EDUCATIONAL ORGANIZATION
BYLAWS
ARTICLE I. NAME
The name of this organization shall be the World Professional Association for
Transgender Health, Inc. (WP ATH), formerly known as the Harry Benjamin
International Gender Dysphoria Association, Incorporated (HBlGDA), hereinafter
referred to as "the Association."

ARTICLE II. PURPOSE
The Association's stated purpose is to provide a mechanism whereby
professionals from various subspecialties of such disciplines as medicine, psychology,
and the law may interact and communicate with each other to share research and clinical
practice experience affecting the health and well-being of transsexual, transgender, and
gender-nonconfonning people.
The Association will promote meetings of interested professionals from a variety
of professions and will encourage the dissemination of knowledge and best practice
guidelines regarding gender dysphoria, transsexualism, and transgender health and wellbeing in general, to the professions and to the general public.

ARTICLE III. OFFICES
Section One. Incorporation. The Association is incorporated in the State of Texas.
Section Two. Principal Office. The Association will have a legal office ("WPATH
Office") associated with the business address of the Executive Director and /or the
location where the day-to-day business functions of the Association are conducted.

ARTICLE IV. GOVERNMENT

Section One. Voting Membership. The Full, Honorary, and Emeritus members of
this Association shall be the voting membership.

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 55 of 76 • PUBLIC •

PUBLIC
2
Section Two. Board of Directors. The administrative body of this Association shall be
the Board of Directors, which includes seven (7) at large members, one ( l) student
liaison (non-voting), and the five (5) Officers of the Association. One (I) additional
voting Board member shall represent each duly authorized Regional Affiliate of the
Association. All members of the Board of Directors must also be members in good
standing of the voting membership.

ARTICLE V-A. BOARD OF DIRECTORS AND OFFICERS
Section One. General Powers. The affairs of the Association shall be managed by its
Board of Directors, who will be elected by the membership, except as noted below,
Section Two. Nwnber. Tenure, and Qualifications. The number of At-large Directors
shall be seven (7). Each At-large Director shall serve for a tenn of four (4) years or until a
successor has qualified. At-large Directors may succeed themselves without limitation for
one term, for a total of eight (8) years. However, an At-large Director is not prohibited
from serving as an Officer or as a Regional Affiliate Organization Director after eight
years of Board service. Similarly, after eight years on the Board and two years off the
board, any fonner Director is again eligible to be nominated and elected to another Board
tenn. At-large Directors serve the entire Association, and may not represent regional or
other member blocks. At-large Directors may not serve as Regional Directors
simultaneously while serving as an At-large Director. No person may hold or run for two
or more positions on the Board at the same time.
Section Three: Regional Directors. Regional Affiliate Organizations of the Association
may be formed to further professional communication, education and training, and policy
efforts within a specific geographic region or country to provide greater attention to local
members and local issues than is possible or practical to be tended to by the entire
S:\CI.INICIWPATl! CIJltlt£NT\Bylawc,. o,,..,_... .t LcpMs,ociation Lcpl ~\Byl&..,IO,n,:nt APPllOVEI> by MClllben 1-2l•20"

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 56 of 76 • PUBLIC •

PUBLIC
3

WPATH Membership. Regional Affiliates may elect one (I) representative Director to
the WPATH Board for a tenn of two (2) years in elections that are conducted within the
specific region, such that only voting members from that region shall elect the Regional
Director. Regional Directors may be re-elected for two (2) subsequent consecutive tenns
for the total service duration of six (6} years, after which they are not precluded from
running for an At-large Director position or an Officer position with the Association.
They may also run for election again as a Regional Director after standing down for at
least one two (2) year term.
Section Four: Regional Affiliate Leadership. Regional Affiliate Organizations shall be
constituted by a local leadership. Each Regional Affiliate Organization shall have its own
operating agreement with WPATH. Regional Affiliate Organizations must be approved
by the WPATH Board of Directors. Upon the chartering of the Regional Affiliate
Organization, such entity must be re-approved every two {2} years by the WPATH Board
of Directors to remain recognized as an Affiliate Organization. lt is recommended that
Regional Organizations be led by at least two Co-chairs from the region. Directors and
Co-chairs may be volunteers from the time of Affiliate establishment to the time of the
next regular Regional election, as determined by the Regional leadership. Thenceforward,
Regional Officers and Directors shall be elected by the Regional Membership every two
(2) years thereafter. Regional Affiliate Co-chairs may also establish other supporting
positions as needed to operate the Organization. Regional Affiliate Organizations are
responsible for conforming to the relevant laws governing professional educational
associations in the country where they are constituted, and may establish their internal
governance entirely according to local law or custom, including the capacity to refer to
themselves as a WPATH Region, Regional Affiliate, or Regional Chapter, or other
S:\CUNICIWPATH CIJ'UENT\By!awt,_Orpniwion A t.cpM&socialion !.o Lepl Doc:wncnbll.Bylawt\Cunmi "1PllOVED by Mtlllbcn 1,22•2016
0

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 61 of 76 • PUBLIC •

PUBLIC
8
and financial reports to the Board of Directors on an annual basis. They will have
signature authority on all financial accounts of the Association. In addition, the Treasurer
will, in consultation with the Board, order an audit of the financial records of the
Association at any time. Overall, the Treasurer will insure the fiscal responsibility of the
Association. They will serve a term of roughly two (2) years and may succeed themselves
only once for a total tenn of four (4) consecutive years.

Section Five. Secretary. The Secretary will monitor the activity of Committees, and, in
general, perform such other duties as from time to time may be assigned to them by the
President or by the Board of Directors. They will serve a tenn of roughly two (2) years
(as described above) and may succeed themselves only once for a total of four (4)
consecutive years.

Section Six. Past President. When the President's term expires, they will become the
immediate Past President for a tenn of roughly two (2) years.

ARTICLE V-C: EXECUTIVE DIRECTOR

The Executive Director serves as the operating officer of the Association and carries
out or oversees the day- to-day work of the Association. The Executive Director is
selected by the Board of Directors and may be paid a professional fee negotiated by
them. Under the broad approval of the Board of Directors, the Executive Director
implements the policies and plans of the Association and serves as an information
representative to external and internal sources. The Executive Director maintains a
working relationship with the President to whom they are directly responsible. The
Executive Director works closely with the Board of Directors and with the Committee
Chairs and Regional Co-Chairs in such a way as to develop the services of the

S\Cl~Wl'ATH CVRll1''1'\Byfr,,,s,_~ • tes.tlAnocmiotl Lopl 0ocu ......1B)ia"""°"""" APPROVED by Mfflleerl 1.22.2:01&

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 62 of 76 • PUBLIC •

PUBLIC
9

Association. The Executive Director must provide effective and efficient management
resulting in productive performance and constructive growth of the Association. The
Executive Director is responsible for the management and administration of the
budget, and collects dues from the membership. They will have signature authority on
all financial accounts of the Association. The Executive Director will also perfonn
certain duties of Secretary of the Association by ensuring that records of the meetings
of the Board of Directors and Officers, as well as the minutes of the biennial general
membership meetings, are properly taken and maintained by office staff, and by
ensuring that notices are duly given in accordance with the provisions of these bylaws
or as required by law. The Executive Director is responsible for overseeing the web
site of the Association, production and distribution of correspondence or newsletters to
the membership as detennined by the Board of Directors, as wen as the updating and
maintaining of the membership list. The Executive Director shall attend all meetings
of the Executive Committee and Board of Directors (unless excused), and shall both
inform and advise the Board on all business matters of the Association; however, as an
employee of the Association, they are not entitled to a vote in any matters considered
for decision by the Board.
ARTICLE VI. MEMBERSIDP
Section One. Honorary Members. The Board of Directors may, from time to time,

designate persons as honorary members of the Association. Such persons will have full
voting rights in the Association and the requirement to pay dues to the Association will
be waived.

S

, ICUNIC\Wl'ATH

C'U'RRENT\11,-t,...,_~ L,pl\Assoct, 1,22-2016

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 63 of 76 • PUBLIC •

PUBLIC
10

Section Two. Full Membership.
a. Persons may apply or be nominated for membership in the Association.
b. A person who is nominated must also complete an application form and meet
all of the requirements contained in points c and d below.

c. Applicants must be able to demonstrate a relevant professional qualification
in any discipline of:
•
•
•
•
•
•
•
•
•
•
•

Medicine
Law
Marriage and Family Therapy
Psychology
Psychotherapy
Speech/ Voice Therapy
Sexology
Social Work
Sociology
Education
or other relevant discipline in the field of transsexual, transgender, or gendernonconforming people's health, well-being and care,

or, experience and background in these disciplines or any other related
profession or discipline which contributes to the well-being of transsexual,
transgender, and/or gender-nonconfonning people,
d. Applicants must also include a payment of their annual membership fee as
prescribed by the Board of Directors with their application. On approval of their
membership such payment will be transferred into the hands of the Association.
e. Approval for membership may be given by the Executive Director or any
designated member of the Board as proposed by the Executive Committee.
f. Persons approved will be regarded as full members with full voting rights.
g. If a person wishes to appeal a membership decision, they should contact the office
of the Executive Director.
S:ICUNIC\WPATH CURRl!NnB)llowt, Otpl>i:alio~ A LteallAlsocialion Ufa! Doautaa\Byl&wt\Cuncnt APl'ROV'EJ> l,y Membm 1,ll,201~

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 64 of 76 • PUBLIC•

PUBLIC
11

Section Three. Emeritus Membership. Persons who are retired may become Emeritus
members and be eligible for a reduced membership fee upon providing evidence of
retirement. Emeritus members must have been full members of the Association before
retirement for at least five consecutive years immediately before applying for Emeritus
membership. Emeritus members have full voting rights.
Section Four. Student Members. Persons applying for membership in this Association,
and proving status as a registered student in a tenninal degree program pertaining to
transgender health, upon nomination by a full member of the Association, and upon
payment of student dues as set by the Board of Directors, will be regarded as student
members of the Association. Student members do not have voting rights unless they
have attained approved status as a Full member and therefore qualify to vote.
Section Five. Supporting Members. Other persons applying for membership in the
Association who do not have any relevant professional connection with the field, yet
pay dues as prescribed by the Board of Directors, will be regarded as supporting
members of the Association without voting rights. Group memberships, if approved,
will also be classified as supporting members.

Section Six. Regional Affiliate members. Regional Affiliate members automatically
become members ofWPATH, and WPATH members automatically become members of
any Regional Affiliate that is duly constituted in their home region. Regional Affiliate
membership criteria is the same as that for WPATH membership, as described in this
Article (Article VI. MEMBERSHIP). Regional Affiliate members shall pay membership
dues to WPATH in an amount established by the Board of Directors. In some cases,
depending on the Regional Affiliate operating agreement with WP ATH, certain funds
may be remitted to the Regional Affiliate to assist in supporting the Affiliate's work on
S:ICLINICIWl'ATH ct/lUteNT\8)'1aw1,_0lOVED

'Y

M

. . . . . .

1-22
-

1016

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 66 of 76 • PUBLIC •

PUBLIC
13

ARTICLE VIII. DUES
Section One. Annual dues. The annual dues for honorary members will be waived; the
annual dues for all membership categories will be determined by the Board of Directors.
Dues must be paid by the renewal date specified or the member wiH be dropped from
membership.
ARTICLE IX. MISCELLANEOUS
Section One. Books and records. The Association shall keep correct and complete books
and records of account and shall also keep minutes of the proceedings of its Board of
Directors and committees having any of the authority of the Board of Directors.
Regional Affiliate Co-chairs shall maintain records of Affiliate business meetings, and
any Director elected by a Regional Affiliate shall document all joint business of the
Affiliate and of the Association in which they participate in memoranda that shall
become the property of the Affiliate Office, with copies delivered promptly to the
WPATH Office.
Section Two. Fiscal year. The fiscal year of the Association shall be determined based
on good accounting and bookkeeping practices.
Section Three. Coi:porate seal. The Board of Directors shall provide a coiporate seal
with the name of the Association thereon.
Section Four. Waiver of Notice. Whenever any notice is required to be given under the
provision of the Texas Non-Profit Coiporation Act, or under the provisions of The
Articles of Incorporation or the Bylaws of the Association, a waiver thereof, in writing,
signed by the person or persons entitled to such notice whether before or after the time
stated therein, shall be deemed equivalent to the giving of such notice.

S:ICLOOC\WPATH ctlltJt£lm8yl&wa...Obcn l •ll-2016

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 67 of 76 * PUBLIC *

PUBLIC
l4

ARTICLE X. ENACTMENT OF THESE BYLAWS
These Bylaws shall take effect upon approval of the majority vote of eligible voting
members.

ARTICLE XI. AMENDMENTS
Section One. Amendment to Bylaws. The current Bylaws shall be posted on the
Association's web site for members. These Bylaws may be altered, amended or appealed
by vote of the voting membership at such time, place, and by such methods as directed by
the Board of Directors. Any proposed alterations, amendments, or suggested repeals of
the Bylaws must be approved by majority vote of the membership's eligible votes cast.
upon recommendation by the Board of Directors. Members may submit suggested
amendments to the Board of Directors for consideration.

ARTICLE XII. VOTING
Section One. Vote required. All votes taken by the Board of Directors and by the voting
membership shall require a majority of votes cast unless otherwise specified by these
Bylaws. In the case of votes taken by the Board of Directors, a quorum of directors must
be present before the vote is taken, except as specified as above. However, in the case of
a vote by the Board of Directors to remove an officer, a two-thirds vote of the directors
is required. All votes taken by the membership shall be conducted by electronic ballot
using either email or the Association web site or another web site approved by the
Executive Director and Executive Committee. A majority of ballots cast detennines the
outcome.

ARTICLE XIII. COMMITTEES
Section One. Appointment. Committees may be established by the Board of Directors.
Committees should include at least three (3) persons, including, if possible, one (1)
S:IC1.INIC\WPATH CUltU!mBylalVI. O!p,Wlrioo A Lcsal\Atooclado,, Lop.I ~ \ B y i a ~ Al'PROVEO by M
Monday. February 2, 2026 5:26 PM
Schuyler Standley; Abbe David Lowell; David Dale; Bella Oishi
Chiang. Annie; Clausen, Hans
FTC CID to WPATH - Friday's Meet & Confer

Counsel,
Thank you for meeting with us last Friday, January 30, about the Commission's Civil Investigative
Demand (CID) to your client World Professional Association for Transgender Health (WPATH).
During that meet and confer, we each raised several matters, and we offered you an extended
production schedule. Those issues are outlined in more detail below. Additionally, we are
available tomorrow at noon for a further meet-and-confer and will circulate an invitation.

I.

Document Retention and Production

During our meeting, you confirmed that you have either asked WPATH to impose a litigation hold,
or that it has, at your direction, already imposed a litigation hold, which we appreciate. We also
requested information concerning, but you were not yet prepared to discuss, the following: (1}
where or how your client's documents relevant to the requests in the Commission's CID are
stored, (2) details on the number or identity of any custodians with relevant documents
responsive to the CID in their possession, (3) your process for reviewing those documents, to
determine responsiveness as well as your privilege review and how or when you would assert
protected status claims, and (4) whether you plan to use Technology-Assisted Review {TAR) or
Artificial Intelligence (Al) as part of your compliance with our CID requests. We explained that if
you plan to use any Al•assisted program or tool in connection with your response, you must
disclose this to us. You may not use TAR or Al without our consent, although we would work
with you in good faith to attempt to reach an agreement should you propose to use TAR or Al.
With respect to privilege logs, we explained that WPATH must comply with Commission rules,
and it must produce logs contemporaneously with the associated production. You asked to
discuss the process for privilege review at a later time, and we are always willing to discuss this,
or anything else, with you.

II.

Issues You Raised

At last week's meet-and-confer, you sought to clarify two points: (1) whether the FTC has
authority to issue the CID; and (2) that your client's documents or responses may implicate
confidences or privileges given their relation to medicine or the medical field. First, although we

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 72 of 76 • PUBLIC •

PUBLIC

do not necessarily agree that WPATH is not engaged in "commerce;' as you appeared to
understand that term, we explained that the Commission's authority to issue CIDs is broader
than its authority to institute litigation; WPATH need only possess information "relevant to"
unfair or deceptive acts in or that affect commercial activity. See 15 U.S.C. 57b1(c)(1 ). Second, we appreciate your client's concerns regarding privacy. Privacy concerns are
important to us as well. Notably, as we explained, the FTC has very strict statutory and
regulatory requirements regarding use and disclosure of data that you produce. These
protections are more than ample and, in any event, we have no ability to agree to something
different than what the law expressly provides. Beyond those points, you did not raise other
issues.

Ill.

Proposal for Production Schedule

We proposed a production schedule, which is reflected below. AssumingWPATH agrees to
accept service, forgo any petition to quash, and continue engaging with us in good faith (all
standard requirements), we will extend the Cl D's return date as follows:
a. By February 16, you will respond fully to Document Request Nos. 1Oand 12;
b. By March 16, you will respond fully to five Document Requests of your choosing and five
Interrogatories of your choosing (except that you may not select Interrogatory 15 or
Request 13 (those logically come last));
c. By April 16, you will respond fully to all remaining Document Requests and
Interrogatories.
For all production deadlines, you will produce the related privilege log simultaneously with your
production. Our proposed production schedule affords you ninety days to complete your
response, which is eminently reasonable, and triple what the CID currently permits. Moreover, it
provides WPATH extensive discretion over the order in which it produces material.
As a formal matter, and in conformance with the applicable rules, we note that Deputy Director
Kate White has endorsed the CID modifications this correspondence contains. We look forward
to talking again tomorrow.
Thanks,

Jonathan Cohen
Chief Litigation Counsel
Bureau of Consumer Protection I Federal Trade Commission
600 Pennsylvania Avenue, N.W., HQ-462 Washington, D.C. 20580
(202) 326-2551 I jcohen2@ftc.gov
2

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 73 of 76 • PUBLIC •

.,

PUBLIC

Exhibit 6

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 74 of 76 *PUBLIC*

PUBLIC

United States of America

FEDERAL TRADE COMMISSION
600 PENNSYLVANIA AVE. NW, CC-9528
WASHINGTON, 0C 20580

Bureau of Consumer Protoction
Chief Lltigutton Cowiscl

Jonathan Cohen
(202) 326-2551; jcoben2@ftc.gov

February 5, 2026

VlAEMAIL
Abbe David Lowell, Esq. (adlowell@lowellandassoe.1ates.com)
Isabella Oishi, Esq. (ioishi@lowellandassocaites.com)
Schuyler Standley, Esq. (sstandley@lowellandassociatcs.com)
Lowell & Associates, PLLC
1250 H Street NW, Second Floor
Washington, DC 20005
(202) 964-6110
Re:

Civil Investigative Demand to WPATH

CounseL
Thank you for meeting with us again earlier this week (February 3) regarding the Commission's
CID. We discussed several matters, some of which we outline below. We also respond to certain
requests for modifications or clarifications that you made for the first time on February 3, and we will
continue to consider any such requests you make.
I;

Scope of the CID-Definition of"WPATH,, and Related Issues

To begin, you raised concerns about the First Amendment including, in particular, your
hypothesis that the CID will have a "chilling effect'' on WPATH's speech or associational rights. To
the extent this sort of First Amendment analysis applies at all, we agreed with you that it would be
your burden to prove any alleged "chill"--a burden you expressed confidence (if not certainty) that
you could meet. To the extent you have evidence you would like us to consider, or even argument
more specific than simply a general, unsupported "chill" claim, we would welcome the opportunity to
evaluate it and advise our client accordingly.
To the extent your argument turns on the CID's definition of WPATH, we encourage you to
reconsider. The definition includes standard language encompassing "subsidiaries, unincorporated
divisions, joint ventures, operations under assumed names, and affiliates, and all directors, officers,

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 614846 -PAGE Page 75 of 76 • PUBLIC •

PUBLIC
CIDtoWPATH
Page2

members, employees, agents, consultants, and other persons wo.rking for or on behalf of the
foregoing." Io this context, "members" refers to LLC members; please do not ovenead the word to
support a First Amendment argument where none exists. In any event, and as we explained yesterday,
you should construe "members" in the definition to include only "LLC members," to the extent any
exist. This CID docs not seek a response on behalf of thousands of individual WPATH members,
nor is that our intent.
Finally, we asked you whether, in your view, any particul.a.t requests or interrogatories were
somehow unconstitutionally intrusive. You did not identify specific examples during our mee~ but
you offered to provide them to us, a.nd we agreed to consider whatever perspective or parttculat
arguments you share. If there is a way that we can address your concerns, meritorious or otherwise,
and still obwn the information our investigation requires, we would agree to further limitations.
Whatever the outcome, we welcome the dialogue, and we appreciate your commitment to identify any
potentially problematic specifications so that we can at least attempt to resolve your concerns.
II.

Scope of the CID-Other Definitions

You also asked us to clarify what "substantiation" means> and we explained that
"substantiation" is a term-of-art in consumer protection jurisprudence. To the extent useful, we can
direct you to potentiilly applicable caselaw establishing basic substantiation principles in consumer
protection matters.
You also argued that "safe" is vague as applied to the procedures at issue. We disagree. As
we explained, "safe" means what consumers (10 this case, parents or minors) would understand it to
mean in the context at hand. The fact that a CID does not define ev~ word therein does not render
the undefined words necessarily ambiguous. However, if you would like to propose a specific, more
detailed definition of "safe," we would consider it as long as the proposal maintains fidelity to the
word's common meaning to consumers in this context.
Finally, you asked whether we viewed social transition as a "medical intervention." Although
the CID nowhere references "social transition," we confirm that a treatment exclusively involving
social transition is not a "medical intervention" within the CID's scope.

Ill.

Scope of the CID-Other Issues

At your request. we clarified that WPATH docs not need to produce information publicly
available on its website.
Also at your request, we reiterated that the focus of this investigation .is treatment provided to
minors (indeed, various requests refer specifically or "PGDT," or "Pediatric Gender Dysphoria
Treatment''). Other infonnation not expressly limited to minors is or reasonably could be probative,
however, with respect to communications made to minors and/ or their parents, or other associated
issues. If this is an area that warrants further discussion. please advise.
Separately, you indicated that WPATH sometimes receives what you termed "hate mail," and
you asked us about that in light of our request seeking, among other things, "complaints." Requests
for complaints are swidard in FTC investigations and consumers sometimes react with anger when
services do not ptoduce the claimed results. We reiterate that we need all responsive complaints.
Other than those issues identified above, you confirmed that there were no other matters you
wanted to raise during our call.

2

FEDERAL TRADE COMMISSION I OFFICE OF THE SECRETARY I FILED 02/09/2026 OSCAR NO. 61 4846 -PAGE Page 76 of 76 • PUBLIC•

PUBLIC

CID to WPATII
Pagc3

III.

Document Retention and Production

As with our prior mect-and-confe.t, we again .raised the following issues: (i) how documents
responsive to the requests in the Commission's CID are stored or maintained and what records
management systems contain such material; (11) the custodians that would have responsive documents
in their possession, custody, or control; (w) your process for reviewing those docwneots to determine
responsiveness as well as your privilege review and how or when you would assert protected status
cl.aims; and (iv) whether you plan to use certain tools, like AI or Technology Assisted Review (fAR),
to .review and identify responsive documents. However, you indicated that you were not prepared yet
to discuss these issues. Rather, you characterized them all as "fo.r a later time."

IV.

Production Schedule

You further indicated that WPATH was not prepared to discuss the production schedule we
proposed on January 30 during our initial meet-and-confer and that we subsequently provided to you
in writing.
As a formal matter, and in conformance with the applicable rules, we note that Deputy
Director Kate White has endorsed the CID modifications this correspondence contains. We look
forward to hearing from you.

/

CC:

Via Email
Kate White, Deputy Ditecto.r
Annie Chaing
Jennie Hitchcock
Hans Clausen
Bureau of Consumer Protection
Fede.tal Trade Commission
David]. Dale (ddale@staubanderson.com)
Staub Anderson LLC

3

• f Litigation Counsel
Bureau of Consumer Protection

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/documents/agency%3Aftc%3Aa4d0ff26a1d650bd. Public record. Not legal advice.
